Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
J&J said it is seeking a preliminary injunction for Samsung Bioepis' close copy of Stelara over an unauthorized sublicense ...
Selarsdi is approved by the FDA in several presentations, including 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled ...
Teva Pharmaceuticals and Alvotech have announced the US launch of the Selarsdi (ustekinumab-aekn) injection, a biosimilar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback